Los puntos clave no están disponibles para este artículo en este momento.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed
Share your take
Add a clinician perspective alongside expert commentary.
Lin et al. (Thu,) studied this question.